• Slider Image
  • Slider Image
  • Slider Image

In the Press


February 6, 2020

Cancer-Causing Culprits Could be Caught by their DNA Fingerprints

Causes of cancer are being catalogued through an international study revealing the genetic fingerprints of DNA-damaging processes that drive cancer development, featuring Ludmil Alexandrov, PhD.


February 3, 2020

Measuring 'stickiness' of cancer cells could improve prognostic evaluation of tumors

A team of researchers led by the University of California San Diego has created a device that measures how "sticky" cancer cells are, which could improve prognostic evaluation of patient tumors, featuring Anne Wallace, MD.


February 3, 2020

With Equal Access to Care, Blacks, Whites Have Similar Prostate Cancer Outcomes

Survival rates are similar for black and white prostate cancer patients who are treated in an equal-access health system, researchers say, featuring Brent Rose, MD.


January 31, 2020

Anti-carcinoembryonic antigen-related cell adhesion molecule antibody for fluorescence visualization

In this Oncotarget study, the authors test a novel anti-CEACAM antibody conjugated to a fluorescent dye for detection of multiple CEACAM antigens to enhance visualization of colorectal PDOX tumors and metastases in murine models, featuring Michael Bouvet, MD.


January 30, 2020

Increased vegetable consumption fails to reduce risk for prostate cancer progression

There was evidence that men who ate a diet low in fat and high in fruits and vegetables had a lower risk [for] developing prostate cancer, but that was observational, but with no experimental evidence. This study was developed and conducted by J. Kellogg Parsons, MD, MHS and John Pierce, PhD.


January 28, 2020

Stem Cells, CRISPR and Gene Sequencing Technology are Basis of New Brain Cancer Model

Researchers have developed stem cell models that are CRISPR-engineered to have tumor-associated driver mutations in glioblastoma, which harbor essentially all features of patient-derived tumors, including extrachromosomal DNA amplification, featuring senior authors Frank Furnari, PhD and Gene Yeo, PhD.


January 28, 2020

New clinical trials treat patients with high risk for cervical cancer

Dr. Jyoti Mayadev is interviewed regarding new treatments, clinical trials and therapy for patients with cervical cancer and those who have high risk developing it.


January 24, 2020

Scientists Trying to 'Hack' Zika Virus to Kill Brain Cancer

Dr. Jeremy Rich is studying how to take advantage of the mechanisms the Zika virus uses to destroy cells in order to improve glioblastoma therapies.


January 24, 2020

Zika Virus’ Key into Brain Cells ID’d, Leveraged to Block Infection and Kill Cancer Cells

Working independently, two different UC San Diego research teams identified the same molecule — αvβ5 integrin — using brain organoids, tumor organoids and mouse models, featuring Tariq Rana, PhD, and Jeremy Rich, MD.


January 22, 2020

UC San Diego Health Sciences study finds how marijuana accelerates HPV-related head and neck cancer

Joseph Califano III, MD, and team used animal and human cell lines to show that THC turns p38 MAPK on and were able to stop the growth of HPV-positive head and neck cancer by turning off the pathway.


January 17, 2020

Patient Partners: Good friends and great adventures

Dr. Jason Sicklick is a powerful example of what is possible when professionals and families form meaningful partnerships and friendships, in particular for those with rare GISTs.


January 16, 2020

Rise in Colorectal Cancer Among People Younger than 50 Continues: Researchers are looking for risk factors

A team of researchers led by Samir Gupta, MD, performed one of the first large-scale studies looking at risk factors for early-onset colorectal cancer.


December 27, 2019

Dual target CAR T/natural killer cell therapy shows promise for B-cell malignancies

Fate Therapeutics' novel CAR-NK cell construct was designed by the company’s academic collaborator, Dan Kaufman, MD, PhD professor of medicine in the division of regenerative medicine and director of cell therapy at UC San Diego School of Medicine.


December 15, 2019

The Fight Against Lymphoma: New Treatments Unveiled at Cancer Conference

Dan Kaufman, MD, PhD, told Healthline that one trial from the MD Anderson Cancer Center in Ohio has engineered cord blood–derived natural killer cells “with an anti-CD19 CAR with early results showing promising efficacy against B-cell lymphomas.


December 7, 2019

Ibrutinib + Cirmtuzumab in Patients With CLL/SLL or Mantle Cell Lymphoma

A phase I/II trial (NCT03088878) that is evaluating the combination of the Bruton's tyrosine kinase inhibitor ibrutinib plus cirmtuzumab in patients with CLL/SLL or MCL, with lead clinician Michael Choi, MD.


December 4, 2019

Aptose Appoints Rafael Bejar, MD, PhD, as Chief Medical Officer

Aptose Biosciences Inc., a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, announced the appointment of Rafael Bejar, MD, PhD, to the position of Senior Vice President, Chief Medical Officer, effective January 1, 2020.


December 3, 2019

Immunotherapy is safe following chemoradiotherapy for women with node-positive cervical cancer

Results from the NRG Oncology phase I clinical trial NRG-GOG 9929 show that using the immunotherapy drug ipilimumab after chemoradiotherapy (CRT) is tolerated in the curative treatment of women with lymph node-positive cervical cancer, featuring Dr. Jyoti Mayadev.


December 2, 2019

UC San Diego doctors offer update on cancer prevention, genetic testing at La Jolla lecture series

Inherited germline factors found to play bigger role than previously recognized featuring Moores Cancer Center Director Scott Lippman, MD.


November 21, 2019

Non-Coding DNA Located Outside Chromosomes May Help Drive Glioblastoma

Extra DNA scooped up and copied alongside cancer-causing genes helps keep tumors going — elements that could represent new drug targets for brain tumors and other cancers notoriously difficult to treat, featuring co-senior author Jeremy Rich, MD.


November 21, 2019

Could this ring-shaped DNA change how we treat cancer?

Scientists from UC San Diego and Stanford University show that the circular ecDNA in cancer cells outside the chromosome dramatically increases oncogenes, making tumors more aggressive, with co-senior author Paul Mischel, PhD.


» More Press


2020 Symposium


The 16th Industry/Academia "Next Generation Precision Oncology" Symposium will be held on Thursday, February 20, 2020.

More information is located on our symposium page. Keep checking the symposium page for updates.

Program Agenda



8:00AM

Registration and Continental Breakfast
8:30AM

Organizer Welcome
  • Ida Deichaite, PhD, Organizer, UC San Diego Moores Cancer Center
8:35AM

Director’s Welcome: Precancer 2020
  • Scott Lippman, MD, Director, UC San Diego Moores Cancer Center
8:45AM

  • The Emergence of a Pre-Cancer Genomics Atlas
    Ludmil Alexandrov, PhD, UC San Diego Moores Cancer Center
9:00AM

Session: Solid Tumors
  • Chair: J. Silvio Gutkind, PhD, UC San Diego Moores Cancer Center
9:05AM

  • Targeting extrachromosomal DNA (ecDNA), a new approach to treating cancers with high copy number gene amplification
    Zachary Hornby, Boundless Bio
9:20AM

  • Platform Approach to Pancreatic Cancer Therapy
    Gregory Botta, MD, PhD, UC San Diego Moores Cancer Center
9:35AM

  • Pancreatic Cancer Organoids Enable Precision Medicine
    Herve Tiriac, PhD, UC San Diego Moores Cancer Center
9:50AM

  • The Pathology of RET-altered Lung and Thyroid Cancers
    Anthony Sireci, MD, & Cynthia Rubenstein, PhD, Loxo Oncology at Lilly
10:05AM

  • KRAS G12C Inhibition: Opportunities for intersection of targeted therapy and immune checkpoint modifiers
    James Christensen, PhD, Mirati Therapeutics
10:20AM

Session Q&A and Discussion
10:35AM

Break
10:45AM

Duane Roth Achievement Award Presentation
  • Recipient Scott Gottlieb, MD,
    23rd Commissioner of the FDA, AEI Resident Fellow, NEA Partner
10:55AM

Keynote Presentation:
Duane Roth Award Lecture
  • Opportunities through public to advance the care of cancer patients
    Scott Gottlieb, MD, 23rd Commissioner of the FDA, AEI Resident Fellow, NEA Partner
12:00PM

Lunch & Poster Session
1:30PM

Session: Immuno-Oncology
  • Chair: Ezra Cohen, MD, UC San Diego Moores Cancer Center
1:35PM

  • Enabling adoptive cellular therapy against natural ligands
    Stephen Schoenberger, PhD, La Jolla Institute for Immunology, SDCPI, UCSD
1:50PM

  • Patient Experience
    Tamara Strauss, Patient Advocate
2:00PM

  • Personalized NeoAg vaccines
    Aaron Miller, MD, PhD, UC San Diego Moores Cancer Center
2:15PM

  • Development of genetically engineered T cell products for cancer therapy
    Adrian Bot, MD, PhD, Kite, a Gilead Company
2:30PM

  • The Yin and Yang of CAR T: Reaching the Full Potential of Cell Therapy
    William Go, MD, PhD, A2 Biotherapeutics
2:45PM

  • Pluripotent Cell-Derived Engineered T and NK Cells as a Cornerstone Approach for Off-the-Shelf Cancer Immunotherapy
    Bob Valamehr, PhD, Fate Therapeutics
3:00PM

Session Q&A and Discussion
3:15PM

Break
3:25PM

Session: Hematology/Oncology
  • Chair: Catriona Jamieson, MD, PhD, UC San Diego Moores Cancer Center
3:30PM

  • State of the Art Experimental Models for Aggressive Multiple Myeloma
    Fotios Asimakopoulos, MD, PhD, UC San Diego Moores Cancer Center
3:45PM

  • Protein Neddylation: A New Target for Therapeutics in Acute Myeloid Leukemia
    Ronan Swords, MD, PhD, AbbVie
4:00PM

  • Precision Therapy of Relapsed/Refractory EBV+ Lymphomas Utilizing an Oral Inducer of Viral Kinases to Activate an Anti-tumor Prodrug
    Ivor Royston, MD, Viracta Therapeutics
4:15PM

Session Q&A and Discussion
4:35PM

  • Fireside Chat: Are we about to see the full value of diagnostics realized across drug development and patient care?
    Mike Pellini, MD, Section 32
    Moderated by Ian Stone, Canale Communications
5:05PM

Closing Remarks
  • Catriona Jamieson, MD, PhD, UC San Diego Moores Cancer Center
5:10PM

Symposium Reception at Goldberg Auditorium Foyer




Past Symposium Highlights


The 15th Industry/Academia "Next Generation Precision Oncology" Symposium highlights are located here.

2018 Keynote Presentation: Duane Roth Award Lecture
Engineering T-Cells: The Sky is the Limit


Carl June, MD
University of Pennsylvania School of Medicine




2018 Keynote Presentation:
A New Model for Translational Research in the Nonprofit Sector


Peter Schultz, PhD
California Institute for Biomedical Research



2018 Welcome Remarks


Ida Deichaite, PhD, Symposium Organizer, UC San Diego Moores Cancer Center
Pradeep Khosla, PhD, Chancellor, UC San Diego




Visit our Symposium page for more Symposium Featured Talks.



2015 Symposium Slideshow from MCC Industry Relations on Vimeo.


Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!



San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by 2014 Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here


Our Symposium Page




9th Symposium Featured on San Diego ABC 10 News


Michael Chen from San Diego ABC 10 News covering the 9th MCC Industry/Academia Translational Oncology Symposium - 4/11/13 6PM from MCC Industry Relations on Vimeo.

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press